NATCO files generic Erdafitinib Tablets in USA

Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma

Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

This product would be manufactured at Lupin's Nagpur facility in India

Dr Reddys Laboratories signs for consumption of renewable energy

Lupin receives approval from USFDA for Chlorpromazine Hydrochloride Tablets USP

Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.

Granules India announces approval for Acetaminophen and Ibuprofen Tablets

This product will be launched through Granules Consumer Health (GCH) division

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course

This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries

Lupin receives tentative approval from USFDA for Dolutegravir Tablets for oral suspension

Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)

Zydus receives final approval from the USFDA for Oxcarbazepine Tablets

The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)

Cipla bags sustainable companies rankings for 2022-23

Cipla has a robust governance model focused on sustainability

Apex laboratories introduces OVAPEX Tablets for managing PCOS & female infertility

OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts